182 related articles for article (PubMed ID: 21350364)
1. Predictors of survival after a diagnosis of non-Hodgkin lymphoma in a resource-limited setting: a retrospective study on the impact of HIV infection and its treatment.
Bateganya MH; Stanaway J; Brentlinger PE; Magaret AS; Wald A; Orem J; Casper C
J Acquir Immune Defic Syndr; 2011 Apr; 56(4):312-9. PubMed ID: 21350364
[TBL] [Abstract][Full Text] [Related]
2. Cancer in resource-limited settings.
Krown SE
J Acquir Immune Defic Syndr; 2011 Apr; 56(4):297-9. PubMed ID: 21350363
[No Abstract] [Full Text] [Related]
3. Non-Hodgkin's lymphoma in patients with human immunodeficiency virus infection in Taiwan.
Yang CJ; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
J Microbiol Immunol Infect; 2010 Aug; 43(4):278-84. PubMed ID: 20688287
[TBL] [Abstract][Full Text] [Related]
4. Outcome in patients with non-hodgkin lymphoma and with or without human immunodeficiency virus infection.
Spina M; Carbone A; Vaccher E; Gloghini A; Talamini R; Cinelli R; Martellotta F; Tirelli U
Clin Infect Dis; 2004 Jan; 38(1):142-4. PubMed ID: 14679461
[TBL] [Abstract][Full Text] [Related]
5. HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy.
Achenbach CJ; Buchanan AL; Cole SR; Hou L; Mugavero MJ; Crane HM; Moore RD; Haubrich RH; Gopal S; Eron JJ; Hunt PW; Rodriguez B; Mayer K; Saag MS; Kitahata MM;
Clin Infect Dis; 2014 Jun; 58(11):1599-606. PubMed ID: 24523217
[TBL] [Abstract][Full Text] [Related]
6. Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.
Polesel J; Clifford GM; Rickenbach M; Dal Maso L; Battegay M; Bouchardy C; Furrer H; Hasse B; Levi F; Probst-Hensch NM; Schmid P; Franceschi S;
AIDS; 2008 Jan; 22(2):301-6. PubMed ID: 18097233
[TBL] [Abstract][Full Text] [Related]
7. Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy.
Chao C; Xu L; Abrams D; Leyden W; Horberg M; Towner W; Klein D; Tang B; Silverberg M
AIDS; 2010 Jul; 24(11):1765-70. PubMed ID: 20453630
[TBL] [Abstract][Full Text] [Related]
8. Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era.
Gopal S; Patel MR; Yanik EL; Cole SR; Achenbach CJ; Napravnik S; Burkholder GA; Reid EG; Rodriguez B; Deeks SG; Mayer KH; Moore RD; Kitahata MM; Eron JJ; Richards KL
J Natl Cancer Inst; 2013 Aug; 105(16):1221-9. PubMed ID: 23892362
[TBL] [Abstract][Full Text] [Related]
9. Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort.
Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
Int J Cancer; 2015 Nov; 137(10):2443-53. PubMed ID: 25976897
[TBL] [Abstract][Full Text] [Related]
10. Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study.
Wang Q; De Luca A; Smith C; Zangerle R; Sambatakou H; Bonnet F; Smit C; Schommers P; Thornton A; Berenguer J; Peters L; Spagnuolo V; Ammassari A; Antinori A; Quiros-Roldan E; Mussini C; Miro JM; Konopnicki D; Fehr J; Campbell MA; Termote M; Bucher HC;
Ann Intern Med; 2017 Jan; 166(1):9-17. PubMed ID: 27750294
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors after non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus: Aquitaine Cohort, France, 1986-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).
Thiessard F; Morlat P; Marimoutou C; Labouyrie E; Ragnaud JM; Pellegrin JL; Dupon M; Dabis F
Cancer; 2000 Apr; 88(7):1696-702. PubMed ID: 10738229
[TBL] [Abstract][Full Text] [Related]
12. HIV-associated non-Hodgkin's lymphoma: experience from a regional cancer center.
Sharma A; Bajpai J; Raina V; Mohanti BK
Indian J Cancer; 2010; 47(1):35-9. PubMed ID: 20071788
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy.
; Bohlius J; Schmidlin K; Costagliola D; Fätkenheuer G; May M; Caro Murillo AM; Mocroft A; Bonnet F; Clifford G; Touloumi G; Miro JM; Chene G; Lundgren J; Egger M
AIDS; 2009 Sep; 23(15):2029-37. PubMed ID: 19531926
[TBL] [Abstract][Full Text] [Related]
15. Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma.
Shepherd L; Ryom L; Law M; Hatleberg CI; de Wit S; Monforte AD; Battegay M; Phillips A; Bonnet F; Reiss P; Pradier C; Grulich A; Sabin C; Lundgren J; Mocroft A
J Natl Cancer Inst; 2018 Jun; 110(6):598-607. PubMed ID: 29267895
[TBL] [Abstract][Full Text] [Related]
16. Contribution of HIV infection to mortality among cancer patients in Uganda.
Coghill AE; Newcomb PA; Madeleine MM; Richardson BA; Mutyaba I; Okuku F; Phipps W; Wabinga H; Orem J; Casper C
AIDS; 2013 Nov; 27(18):2933-42. PubMed ID: 23921614
[TBL] [Abstract][Full Text] [Related]
17. Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural Uganda.
Homsy J; Moore D; Barasa A; Were W; Likicho C; Waiswa B; Downing R; Malamba S; Tappero J; Mermin J
J Acquir Immune Defic Syndr; 2010 Jan; 53(1):28-35. PubMed ID: 19797972
[TBL] [Abstract][Full Text] [Related]
18. CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi.
Gopal S; Fedoriw Y; Kaimila B; Montgomery ND; Kasonkanji E; Moses A; Nyasosela R; Mzumara S; Varela C; Chikasema M; Makwakwa V; Itimu S; Tomoka T; Kamiza S; Dhungel BM; Chimzimu F; Kampani C; Krysiak R; Richards KL; Shea TC; Liomba NG
PLoS One; 2016; 11(3):e0150445. PubMed ID: 26934054
[TBL] [Abstract][Full Text] [Related]
19. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
Gingues S; Gill MJ
HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
[TBL] [Abstract][Full Text] [Related]
20. Quality of life, characteristics and survival of patients with HIV and lymphoma.
Diamond C; Taylor TH; Anton-Culver H
Qual Life Res; 2010 Mar; 19(2):149-55. PubMed ID: 20058087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
